Apr 29, 2024 | Access solutions, Alternative Reimbursement Strategies, Benefits preservation, Cost Savings, Direct-to-Employer Contracting, MedBen Rx, Savings, Spousal limitations
It’s hardly shocking that in a new national benefits employer survey, 29 percent of respondents cited “reducing costs” as the most important consideration for employee benefit decisions. However, the steps some employers are using to lower their...
Jan 22, 2024 | Access solutions, Benefits preservation, MedBen Rx, Pharmacy, Prescription, Specialty Drugs
A recent Segal Health Plan Cost Trend Survey projects 2024 cost trend for prescription drugs to approach 10%… but specialty drug trend alone may reach 15% this year, as increased use of expensive drugs continues to drive costs up. (We’ve actually seen...
Jan 5, 2024 | Access solutions, Acquisition Cost Index (ACI) pricing, Appropriateness Solutions, Benefits preservation, Comparative Effectiveness, Drug costs, MedBen Rx, Pricing solutions, Specialty Drugs
Pfizer, Sanofi, Takeda Pharmaceutical, and other drugmakers will raise the prices of more than 500 drugs in early January, according to an analysis by health care researchers 3 Axis Advisors. Inflation and rising manufacturing costs will contribute to the price...
Aug 7, 2023 | Access solutions, Case Studies, Cost Savings, Drug costs, Limited use HRA, MedBen Rx, Patient advocacy program, Pharmacy, Rx Costs, Savings, Specialty Drugs
With specialty drugs now making up about half of total drug spending – and poised to go even higher as more new specialty drugs roll out every year – the need for workable access solutions grows. Fortunately, MedBen Rx has them. Our unique approach incorporates a...
Mar 6, 2023 | Access solutions, Cost Savings, MedBen Rx, Medicare, Research, Rx Costs, Savings, Specialty Drugs
Employers pay up to 30 times as much for specialty drugs than Medicare does, new research finds. According to the JAMA Health Forum, for the 10 most commonly used specialty drugs, employer-sponsored insurance (ESI) plans paid prices up to 3,350% higher than Medicare....
